Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP)

25 filings reported holding TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share as of Q1 2025.
Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 473,835 shares of 13,424,543 outstanding shares and own 3.53% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (91,496 shares), BlackRock, Inc. (69,580 shares), GEODE CAPITAL MANAGEMENT, LLC (62,037 shares), MILLENNIUM MANAGEMENT LLC (36,861 shares), ROYAL BANK OF CANADA (34,153 shares), HRT FINANCIAL LP (27,189 shares), Caitong International Asset Management Co., Ltd (22,662 shares), STATE STREET CORP (20,053 shares), UBS Group AG (19,969 shares), and CIBC Asset Management Inc (17,568 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.